Latest Entries »

DOVER, DE August 21 2017 / Metatron (OTC PINK: MRNJ), an emerging pioneer of releasing Marijuana & CBD-related apps on iTunes and Google Play, is pleased to announce that it is making efforts to enter the Medical Marijuana Arena to supplement the growing line of CBD health and wellness products.

Update: First Batch of CBD products expected to ship this week!

While all CBD extracts have beneficial wellness qualities, CBD derived from the Marijuana plant contains a greater medicinal value, The CBD that you find online or in the store is derived from agricultural hemp and contains trace amounts of THC (less than .3%), whereas the CBD products found in state-regulated dispensaries are derived from high-resin marijuana and contain different amounts of THC in various ratios to the CBD.

Both agricultural hemp, used for food and fiber, and medical marijuana come from the same plant species known as Cannabis Sativa L. Thus, they can both be referred to as cannabis,  However, there are different subspecies of the plant, containing different constituents and grown in distinct ways. Hemp produces only trace levels of THC and is processed from stems, stalks, and seeds, while medical and recreational cannabis plants are grown for their high resin content, found primarily in the flowers of the plant.

When considering the medicinal aspects of the plant, resin is where the magic is. As it turns out, industrial hemp varieties are not optimal for extracting CBD-rich oil for the very reason that they produce less resin, where most of the CBD content is found.

At Metatron, we see the growing number of States legalizing Cannabis in differing forms and with Twenty-six states and the District of Columbia currently, have laws broadly legalizing marijuana in some form. Three other states will soon join them after recently passing measures permitting the use of medical marijuana.

Seven states and the District of Columbia have adopted the most expansive laws legalizing marijuana for recreational use. Most recently, California, Massachusetts, Maine, and Nevada all passed measures in November legalizing recreational marijuana. California’s Prop. 64 measure allows adults 21 and older to possess up to one ounce of marijuana and grow up to six plants in their homes.

“Cannabis and Cannabis related products are and will be one of the biggest dollar markets in history next to oil and we here at Metatron intend to be a part of this ever growing Industry” stated CEO Joe Riehl. Metatron is working with potential partners to expedite this move into the medical aspect of the Cannabis revolution that has established grow and extraction capabilities established and producing.

Metatron will update soon on when and where these products can be purchased by the consuming public. Metatron has completed its new Corporate website and updates and company information can be found there. The completion of this website is just one more step in Metatron moving towards being a major player in the Cannabis Industry. Shareholders and potential investors can access the website here http://metatroninc.com/ and metatronstock.com

The company is also pleased to announce a formal offer to Buzzlink, a cannabis e-commerce platform for dispensaries and consumers. Buzzlink.com will be financed partially by the issuance of preferred B series shares.

Metatron approved investors can acquire Series B shares in blocks of various sizes starting at 1k and recently increased discounts. The first round investors will receive the highest discount. Series B shares can be redeemed through the Company, are immune to reverse splits, and will convert at 1 B share to 50,000 common shares at a 60% discount. Details available at http://metatroninc.com/series- b/ or http://www.metatronstock.com.

Metatron’s Apps:

iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390 Google Play: https://play.google.com/store/apps/developer? id=Metatron+Inc

Facebook: http://www.facebook.com/metatroninc

Twitter: http://twitter.com/metatroninc

News: http://metatroninc.com/blog

Forward-Looking Statements:

Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement. Metatron does not grow, sell or distribute any substances that violate United States Law or the Controlled Substances Act.

Metatron, Inc.

Joe Riehl 302-861-0431

ir@metatroninc.com

SOURCE: Metatron, Inc.

Advertisements

DOVER, DE / ACCESSWIRE / August 14, 2017 / Metatron (OTC PINK: MRNJ), an emerging pioneer of releasing Marijuana & CBD-related apps on iTunes and Google Play, is pleased to announce that it is making efforts to enter the Medical Marijuana Arena to supplement the growing line of CBD health and wellness products.

Also Metatron will be issuing a special dividend for shareholders of record as of 9/15/2017 with payout date of 10/01/2017…pending FINRA approval, more details in future press releases.

 

explosive-growth-legal-adult-use-medical-marijuana-markets-2014-to-2020

While all CBD extracts have beneficial wellness qualities, CBD derived from the Marijuana plant contains a greater medicinal value, The CBD that you find online or in the store is derived from agricultural hemp and contains trace amounts of THC (less than .3%), whereas the CBD products found in state-regulated dispensaries are derived from high-resin marijuana and contain different amounts of THC in various ratios to the CBD.

Both agricultural hemp, used for food and fiber, and medical marijuana come from the same plant species known as Cannabis Sativa L. Thus, they can both be referred to as cannabis,  However, there are different subspecies of the plant, containing different constituents and grown in distinct ways. Hemp produces only trace levels of THC and is processed from stems, stalks, and seeds, while medical and recreational cannabis plants are grown for their high resin content, found primarily in the flowers of the plant.

When considering the medicinal aspects of the plant, resin is where the magic is. As it turns out, industrial hemp varieties are not optimal for extracting CBD-rich oil for the very reason that they produce less resin, where most of the CBD content is found.

At Metatron, we see the growing number of States legalizing Cannabis in differing forms and with Twenty-six states and the District of Columbia currently, have laws broadly legalizing marijuana in some form. Three other states will soon join them after recently passing measures permitting the use of medical marijuana.

Seven states and the District of Columbia have adopted the most expansive laws legalizing marijuana for recreational use. Most recently, California, Massachusetts, Maine, and Nevada all passed measures in November legalizing recreational marijuana. California’s Prop. 64 measure allows adults 21 and older to possess up to one ounce of marijuana and grow up to six plants in their homes.

“Cannabis and Cannabis related products are and will be one of the biggest dollar markets in history next to oil and we here at Metatron intend to be a part of this ever growing Industry” stated CEO Joe Riehl. Metatron is working with potential partners to expedite this move into the medical aspect of the Cannabis revolution that has established grow and extraction capabilities established and producing.

Metatron will update soon on when and where these products can be purchased by the consuming public. Metatron has completed its new Corporate website and updates and company information can be found there. The completion of this website is just one more step in Metatron moving towards being a major player in the Cannabis Industry. Shareholders and potential investors can access the website here http://metatroninc.com/ and metatronstock.com

The company is also pleased to announce a formal offer to Buzzlink, a cannabis e-commerce platform for dispensaries and consumers. Buzzlink.com will be financed partially by the issuance of preferred B series shares.

Metatron approved investors can acquire Series B shares in blocks of various sizes starting at 1k and recently increased discounts. The first round investors will receive the highest discount. Series B shares can be redeemed through the Company, are immune to reverse splits, and will convert at 1 B share to 50,000 common shares at a 60% discount. Details available at http://metatroninc.com/series- b/ or http://www.metatronstock.com.

Metatron’s Apps:

iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390 Google Play: https://play.google.com/store/apps/developer? id=Metatron+Inc

Facebook: http://www.facebook.com/metatroninc

Twitter: http://twitter.com/metatroninc

News: http://metatroninc.com/blog

Forward-Looking Statements:

Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement. Metatron does not grow, sell or distribute any substances that violate United States Law or the Controlled Substances Act.

Metatron, Inc.

Joe Riehl 302-861-0431

ir@metatroninc.com

SOURCE: Metatron, Inc.

DOVER, DE — August 1, 2017 — InvestorsHub NewsWire — Metatron (OTC PINK: MRNJ), an emerging pioneer of releasing Marijuana & CBD-related apps on iTunes and Google Play, is pleased to announce it has secured a deal that brings a line of full spectrum products into the Metatron line of CBD products.

11

Our newest addition to the CBD product line will add Edible Gummies,Candies,tinctures,oils as well as capsule forms of CBD products. Our CBD Candy and Gummies are infused and NOT dipped or coated and provide a full spectrum profile of all cannabinoids and terpenes naturally found within the highest grade, naturally high CBD, medicinal cannabis strains. We have the most potent and powerful THC free CBD formulations in the world. Our THC free full spectrum oils provide the largest amount of naturally present cannabinoids and diverse terpenoids in the world.

“This newest addition to the Metatron product line will expedite Metatron’s entry into the Cannabis Health and Wellness area by giving such a diverse product line to add to our CBD infused Coffee’s and Tea’s. This newest addition places us well into the mainstream of the burgeoning Cannabis business. This is a direction into profitability for the Company and will increase shareholder value he added.” stated CEO Joe Riehl.

Metatron will update soon on when and where these products can be purchased by the consuming public. Metatron has completed its new Corporate website and updates and company information can be found there. The completion of this website is just one more step in Metatron moving towards being a major player in the Cannabis Industry. Shareholders and potential investors can access the website here http:// metatroninc.com/

The company is also pleased to announce a formal offer to Buzzlink, a cannabis e-commerce platform for dispensaries and
consumers. Buzzlink.com will be financed partially by the issuance of preferred B series shares. For more information, please visit http:// metatroninc.com/series-b/ or http://www.metatronstock.com/.

Metatron approved investors can acquire Series B shares in blocks of various sizes and recently increased discounts. The first round investors will receive the highest discount. Series B shares can be redeemed through the Company, are immune to reverse splits, and will convert at 1 B share to 50,000 common shares. Details available at http://metatroninc.com/series- b/ or http://www.metatronstock.com.

Metatron’s Apps:
iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390 Google Play: https://play.google.com/store/apps/developer? id=Metatron+Inc
Facebook: http://www.facebook.com/metatroninc
Twitter: http://twitter.com/metatroninc
News: http://metatroninc.com/blog

Forward-Looking Statements:
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any

obligation to update information contained in any forward-looking statement. Metatron does not grow, sell or distribute any substances that violate United States Law or the Controlled Substances Act.

Metatron, Inc.
Joe Riehl 302-861-0431 ir@metatroninc.com

SOURCE: Metatron, Inc.

DOVER, DE — July 24, 2017 — InvestorsHub NewsWire — Metatron (OTC PINK: MRNJ), an emerging pioneer of releasing Marijuana & CBD-related apps on iTunes and Google Play, is pleased to announce it is in negotiations with a Colorado Grower and CBD oil manufacturer. This Private Company grows quality Cannabis strains specifically bred for high CBD output.

What we here at Metatron are looking for and believe we have found is an organically grown raw product high in CBD and other medicinal Cannabinoids and terpenes stated CEO Joe Riehl. Our research has found that although Industrial Hemp does indeed contain CBD oil, Hemp is actually grown for its fibrous product and not CBD quality or potency, specific strain growth and only the Flowering parts of the plant used as the source for the CBD oils results in a purer high-quality CBD oil which has a much greater medicinal value he added.

This acquisition will be determined upon the final Due Diligence report and cost analysis factors, we hope to be able to update shareholders in the near future on this target as well as the previously announced deal in the July 18 Press Release said, Mr. Riehl.

Metatron has completed its new Corporate website and updates and company information can be found there. The completion of this website is just one more step in Metatron moving towards being a major player in the Cannabis Industry. Shareholders and potential investors can access the website here http://metatroninc.com/

The company is also pleased to announce a formal offer to Buzzlink, a cannabis e-commerce platform for dispensaries and consumers. Buzzlink.com will be financed partially by the issuance of preferred B series shares. For more information, please visit http://metatroninc.com/series-b/ or http://www.metatronstock.com/.

Metatron approved investors can acquire Series B shares in blocks of various sizes. The first round investors will receive the highest discount. Series B shares can be redeemed through the Company, are immune to reverse splits, and will convert at 1 B share to 50,000 common shares. Details available at http://metatroninc.com/series-b/ or http://www.metatronstock.com.

Metatron’s Apps:

iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390

Google Play: https://play.google.com/store/apps/developer?id=Metatron+Inc

Facebook: http://www.facebook.com/metatroninc
Twitter: http://twitter.com/metatroninc
News: http://metatroninc.com/blog

Forward-Looking Statements:

Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement. Metatron does not grow, sell or distribute any substances that violate United States Law or the Controlled Substances Act.

Metatron, Inc.
Joe Riehl
302-861-0431
ir@metatroninc.com

SOURCE: Metatron, Inc.

metatron otc

DOVER, DE–(Marketwired – Jul 17, 2017) – Metatron (OTC PINK: MRNJ), an emerging pioneer of releasing Marijuana & CBD-related apps on iTunes and Google Play, is pleased to announce it is preparing an LOI (Letter of Intent) for an acquisition of a Private Cannabis Company adding to its growing Cannabis Venture. Additionally, Metatron announces that it is now at current status on OTC markets website, as the company updated and provided the current information required.

Metatron intends to acquire a private cannabis company, created by dedicated professionals who share a passion for mastering the art of cannabis cultivation and manufacturing. The Company seeks to offer dispensaries a wide variety of wholesale cannabis products sourced with the highest standards possible. With each consumer in mind, our mission is to distribute pure, potent and flavorful cannabis products.

“This acquisition will place Metatron miles ahead of the competition having new Cannabis company in its portfolio of Cannabis product producing companies as well as adding potential profits from the sale of raw Cannabis as a product to dispensaries for sales to the consuming public where legal by law and add to our effort in producing products that will aid in the fight of the Opioid crisis that is enveloping the entire world,“ stated CEO Joe Riehl.

“Further information on this acquisition is forth coming and all needed SEC forms will be filed relating to this event in a timely man

explosive-growth-legal-adult-use-medical-marijuana-markets-2014-to-2020

According to ArcView Research and Forbes, the Californian cannabis market alone is expected to reach $2.3B by 2020, and nationally increase 700% over the same time period.

buzz2

The company is also pleased to announce a formal offer to Buzzlink, a cannabis e-commerce platform for dispensaries and consumers. Buzzlink.com will be financed partially by the issuance of preferred B series shares. For more information please visit http://metatroninc.com/series-b/ or http://www.metatronstock.com/

ner,” he said.

Metatron approved investors can acquire Series B shares in blocks of various sizes. The first round investors will receive the highest discount. Series B shares can be redeemed through the Company, are immune to reverse splits, and will convert at 1 B share to 50,000 common shares, details at http://metatroninc.com/series-b/ or http://www.metatronstock.com.

tiffasdf

 

#TiffanyvTwitter Update: Tiffany Dehen’s fight to start unwinding the #VeryFakeNews is officially underway, as outside counsel for both Twitter and USD acknowledged service of process. Check http://www.tiffanydehen.com for updates, including Ms. Dehen’s First Amended Complaint.

5

Metatron is partnering up with Nutraceutical and Skin Care company Kyani who have generated over $250,000,000 in sales worldwide. We are also offering distributor positions for a limited time.

“These products are the best I have ever used and the business opportunity is amazing. I have seen many lives changed physically and financially for the better, highly recommended.” – CEO Joe Riehl.

To sign up or buy products download the app for iPhones or Android:

http://www.teamfusionwebsite.com/mobileapp.php

Choose guest and use referral code: 3193424 or visit website:

https://joereal.kyani.com/en-us/opportunity.html

Videos to watch about Kyani:
Business opportunity: https://youtu.be/5TmmzXs9izE Products https://www.youtube.com/watch? v=le5qkt4oaTE&feature=youtu.be

Metatron’s Apps:
iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390 Google Play: https://play.google.com/store/apps/developer? id=Metatron+Inc
Facebook: http://www.facebook.com/metatroninc
Twitter: http://twitter.com/metatroninc
News: http://metatroninc.com/blog

Forward-Looking Statements: Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward- looking statement. Metatron does not grow, sell or distribute any substances that violate United States Law or the Controlled Substances Act.

Metatron, Inc.
Joe Riehl 302-861-0431 ir@metatroninc.com

%d bloggers like this: